185 related articles for article (PubMed ID: 34761735)
1. The prognostic value of MKL1 in predicting breast cancer immune infiltrates and chemosensitivity.
Hua Y; Yang M
Bosn J Basic Med Sci; 2022 Jun; 22(3):382-394. PubMed ID: 34761735
[TBL] [Abstract][Full Text] [Related]
2. SAP domain-dependent Mkl1 signaling stimulates proliferation and cell migration by induction of a distinct gene set indicative of poor prognosis in breast cancer patients.
Gurbuz I; Ferralli J; Roloff T; Chiquet-Ehrismann R; Asparuhova MB
Mol Cancer; 2014 Feb; 13():22. PubMed ID: 24495796
[TBL] [Abstract][Full Text] [Related]
3. MKL1 is an epigenetic mediator of TNF-α-induced proinflammatory transcription in macrophages by interacting with ASH2.
Song M; Fang F; Dai X; Yu L; Fang M; Xu Y
FEBS Lett; 2017 Mar; 591(6):934-945. PubMed ID: 28218970
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of irradiation-induced mammary cancer metastasis: A role for SAP-dependent Mkl1 signaling.
Asparuhova MB; Secondini C; Rüegg C; Chiquet-Ehrismann R
Mol Oncol; 2015 Oct; 9(8):1510-27. PubMed ID: 25999144
[TBL] [Abstract][Full Text] [Related]
5. Nuclear accumulation of MKL1 in luminal breast cancer cells impairs genomic activity of ERα and is associated with endocrine resistance.
Jehanno C; Fernandez-Calero T; Habauzit D; Avner S; Percevault F; Jullion E; Le Goff P; Coissieux MM; Muenst S; Marin M; Michel D; Métivier R; Flouriot G
Biochim Biophys Acta Gene Regul Mech; 2020 May; 1863(5):194507. PubMed ID: 32113984
[TBL] [Abstract][Full Text] [Related]
6. Activation of the MKL1/actin signaling pathway induces hormonal escape in estrogen-responsive breast cancer cell lines.
Kerdivel G; Boudot A; Habauzit D; Percevault F; Demay F; Pakdel F; Flouriot G
Mol Cell Endocrinol; 2014 Jun; 390(1-2):34-44. PubMed ID: 24721635
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Analysis of Prognostic and Immune Infiltrates for RAD51 in Human Breast Cancer.
Li F; Zhang Y; Shi Y; Liu S
Crit Rev Eukaryot Gene Expr; 2021; 31(4):71-79. PubMed ID: 34587437
[TBL] [Abstract][Full Text] [Related]
8. MKL1 potentiates lung cancer cell migration and invasion by epigenetically activating MMP9 transcription.
Cheng X; Yang Y; Fan Z; Yu L; Bai H; Zhou B; Wu X; Xu H; Fang M; Shen A; Chen Q; Xu Y
Oncogene; 2015 Oct; 34(44):5570-81. PubMed ID: 25746000
[TBL] [Abstract][Full Text] [Related]
9. A novel immune-related prognostic index for predicting breast cancer overall survival.
Yu X; Guo J; Zhou Q; Huang W; Xu C; Long X
Breast Cancer; 2021 Mar; 28(2):434-447. PubMed ID: 33146847
[TBL] [Abstract][Full Text] [Related]
10. Megakaryocytic leukemia 1 (MKL1) ties the epigenetic machinery to hypoxia-induced transactivation of endothelin-1.
Yang Y; Chen D; Yuan Z; Fang F; Cheng X; Xia J; Fang M; Xu Y; Gao Y
Nucleic Acids Res; 2013 Jul; 41(12):6005-17. PubMed ID: 23625963
[TBL] [Abstract][Full Text] [Related]
11. An interaction between MKL1, BRG1, and C/EBPβ mediates palmitate induced CRP transcription in hepatocytes.
Fan Z; Li N; Xu Z; Wu J; Fan X; Xu Y
Biochim Biophys Acta Gene Regul Mech; 2019 Sep; 1862(9):194412. PubMed ID: 31356989
[TBL] [Abstract][Full Text] [Related]
12. MKL1-induced lncRNA SNHG18 drives the growth and metastasis of non-small cell lung cancer via the miR-211-5p/BRD4 axis.
Fan H; Yuan J; Li Y; Jia Y; Li J; Wang X; Li X
Cell Death Dis; 2021 Jan; 12(1):128. PubMed ID: 33500406
[TBL] [Abstract][Full Text] [Related]
13. miR-206 Inhibits Stemness and Metastasis of Breast Cancer by Targeting MKL1/IL11 Pathway.
Samaeekia R; Adorno-Cruz V; Bockhorn J; Chang YF; Huang S; Prat A; Ha N; Kibria G; Huo D; Zheng H; Dalton R; Wang Y; Moskalenko GY; Liu H
Clin Cancer Res; 2017 Feb; 23(4):1091-1103. PubMed ID: 27435395
[No Abstract] [Full Text] [Related]
14. An immune-related risk gene signature predicts the prognosis of breast cancer.
Cao W; Jiang Y; Ji X; Ma L
Breast Cancer; 2021 May; 28(3):653-663. PubMed ID: 33400208
[TBL] [Abstract][Full Text] [Related]
15. Immunodeficiency and severe susceptibility to bacterial infection associated with a loss-of-function homozygous mutation of MKL1.
Record J; Malinova D; Zenner HL; Plagnol V; Nowak K; Syed F; Bouma G; Curtis J; Gilmour K; Cale C; Hackett S; Charras G; Moulding D; Nejentsev S; Thrasher AJ; Burns SO
Blood; 2015 Sep; 126(13):1527-35. PubMed ID: 26224645
[TBL] [Abstract][Full Text] [Related]
16. MKL1 links epigenetic activation of MMP2 to ovarian cancer cell migration and invasion.
Xu W; Xu H; Fang M; Wu X; Xu Y
Biochem Biophys Res Commun; 2017 Jun; 487(3):500-508. PubMed ID: 28385531
[TBL] [Abstract][Full Text] [Related]
17. SYT16 is a prognostic biomarker and correlated with immune infiltrates in glioma: A study based on TCGA data.
Chen J; Wang Z; Wang W; Ren S; Xue J; Zhong L; Jiang T; Wei H; Zhang C
Int Immunopharmacol; 2020 Jul; 84():106490. PubMed ID: 32289666
[TBL] [Abstract][Full Text] [Related]
18. lncRNA TCL6 correlates with immune cell infiltration and indicates worse survival in breast cancer.
Zhang Y; Li Z; Chen M; Chen H; Zhong Q; Liang L; Li B
Breast Cancer; 2020 Jul; 27(4):573-585. PubMed ID: 31960363
[TBL] [Abstract][Full Text] [Related]
19. MKL1 mediates TGF-β-induced CTGF transcription to promote renal fibrosis.
Mao L; Liu L; Zhang T; Wu X; Zhang T; Xu Y
J Cell Physiol; 2020 May; 235(5):4790-4803. PubMed ID: 31637729
[TBL] [Abstract][Full Text] [Related]
20. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
Front Immunol; 2019; 10():6. PubMed ID: 30761122
[No Abstract] [Full Text] [Related]
[Next] [New Search]
